Scilex Holding Company — Form 8-K Summary
Reporting date: November 17, 2022. The filing reports entry into a standby equity purchase agreement and related unregistered equity issuance. It does not provide a new income statement, balance sheet, cash flow statement, or operating-period results.
Material Financing Transaction
- Scilex entered into a Standby Equity Purchase Agreement with YA II PN, LTD., an affiliate of Yorkville.
- Scilex may, but is not obligated to, sell up to $500 million of common stock to Yorkville during the applicable commitment period, which extends through the first day of the month following the 36-month anniversary of the effectiveness of the initial registration statement.
- Shares sold in each advance will generally be priced at 98% of the lowest daily VWAP during the two consecutive trading days beginning on delivery of the advance notice. Scilex may establish a minimum acceptable price.
- Each advance is limited to no more than 200% of the average daily trading volume during the five trading days preceding the advance notice.
- Yorkville is generally restricted from exceeding 4.99% ownership of voting power or common stock and the 19.9% Exchange Cap, subject to specified exceptions.
Fees, Securities Issuance, and Conditions
- Scilex must pay a $10,000 structuring fee to YA Global II SPV, LLC.
- Scilex agreed to issue 250,000 common shares to Yorkville as a commitment fee.
- Yorkville’s obligation to purchase shares is subject to, among other conditions, the SEC declaring effective a registration statement covering the commitment shares and shares issuable under future advances.
- The commitment shares and the referenced securities were issued or are expected to be issued in reliance on the Section 4(a)(2) exemption from Securities Act registration, with Yorkville representing that it is an accredited investor.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, margins, cash flow, debt, cash balances, liquidity ratios, or other operating financial metrics. No advance amount was reported as funded on the filing date. The facility represents potential future equity financing rather than committed proceeds immediately available to Scilex.
Changes Versus the Prior Comparable Period
The filing does not present comparative financial results. The material change disclosed is the establishment of a potential $500 million equity financing facility, together with the commitment fee and associated registration requirements.
Outlook, Risks, and Unusual Items
- Future funding depends on Scilex electing to submit advance notices, market trading volume and price conditions, the applicable ownership and issuance limitations, and satisfaction of Yorkville’s contractual conditions.
- Sales priced at a discount to VWAP could pressure the market price and result in dilution to existing stockholders.
- The number of shares issued in future advances is not specified and will depend on the advance amount, share price, and trading volume.
- The commitment shares create immediate or potential dilution independent of any future advances.
- The filing does not provide management guidance or an updated business outlook.
Key Facts for Investor Verification
- Confirm whether the registration statement was filed and when it became effective.
- Verify whether Scilex has drawn on the facility, the amount drawn, and the number and price of shares issued.
- Review the complete Purchase Agreement, including omitted exhibits and schedules, for additional conditions and exceptions to the Exchange Cap.
- Assess the potential dilution from the 250,000 commitment shares and any future advances.
- Review subsequent SEC filings for changes to the facility, use of proceeds, liquidity needs, and Yorkville ownership.